The Vietnam clinical trials market is anticipated to grow at a CAGR of 6.18% during the forecast period of 2025-2034, driven by the rising prevalence of tropical and infectious diseases in the region. The market growth is driven by the increasing prevalence of chronic and life-threatening diseases such as cancer, diabetes, cardiovascular disorders, and infectious diseases is fueling the demand for clinical research and development of new therapies.
Base Year
Historical Period
Forecast Period
In December 2024, Tam Anh General Hospital in Vietnam joined the VISTA-1 trial for RBS2418, an oral immunotherapy targeting advanced colorectal cancer. This participation underscores Vietnam's growing role in global oncology research and serves as a key driver for market growth by enhancing the country’s capabilities in conducting advanced, high-impact clinical trials.
A key trend in the Vietnam clinical trials market is the rising approval of international drug trials. For instance, in December 2024, the Vietnamese Ministry of Health approved the phase 2A trial of the US-made cancer drug RBS2418.
Key players are undergoing collaborations, fostering a favorable regulatory environment, cost-effective solutions, and access to a diverse patient population, promoting market expansion.
Value in USD Billion
2025-2034
Vietnam Clinical Trials Market Outlook
*this image is indicative*
Clinical trials involve research studies conducted to evaluate the safety and efficacy of medical treatments. Vietnam offers a favorable regulatory environment and a diverse patient population. According to Vietnamese Ministry of Health data, in 2024, the Ministry of Health in Vietnam received only 1.2 trillion VND out of a total capital budget of 120 trillion VND, accounting for just 1%. However, in 2025, the allocation significantly increased to 5.7 trillion VND out of a total budget of 148 trillion VND, representing 3.7%. This substantial rise in funding signals stronger government support for healthcare initiatives, which could positively impact the clinical trials market in Vietnam by enabling greater investment in research infrastructure, regulatory capacity, and public-private partnerships in clinical development.
Rising Prevalence of Tropical and Infectious Diseases Driving the Market Growth
The increasing prevalence of tropical and infectious diseases in Vietnam significantly boosts the clinical trials market. According to the Centers for Disease Control and Prevention, an estimated 250,000 people in Vietnam are living with HIV, underscoring the need for continued medical research. This rising demand for treatments is enhancing clinical trial opportunities, supporting the overall market growth, and positioning Vietnam as a hub for clinical studies.
Some of the notable trends include increasing emphasis on mitigating chronic diseases and adoption of precision medicine.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Phase
Market Breakup by Service Type
Market Breakup by Therapeutic Areas
Market Breakup by Application
Service Types to Lead the Market Segmentation by Therapeutic Areas
The service types encompass laboratory services, bioanalytical testing, decentralized trials, patient recruitment, site identification, and more. Among these, laboratory services are expected to lead, driven by their critical role in diagnostics, data accuracy, and regulatory compliance. The rising demand for precise and timely laboratory testing in clinical trials further reinforces their central importance in supporting efficient and reliable research outcomes.
Oncology to Lead the Market Share by Therapeutic Areas
According to GLOBOCAN 2022, Vietnam reports approximately 180,400 new cancer cases and over 120,000 cancer-related deaths annually. This rising cancer burden is driving significant demand for advanced treatment options. As a result, oncology is expected to dominate Vietnam's clinical trials market, supported by growing interest in targeted therapies, immuno-oncology, and novel cancer treatments. The increasing focus on oncology within the broader therapeutic landscape—which also includes infectious diseases, neurology, metabolic disorders, immunology, cardiology, genetic conditions, and women’s health—highlights Vietnam’s potential as an emerging hub for cancer-focused clinical research and innovation.
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Headquartered in Durham, North Carolina, and established in 1982, IQVIA is a global leader in clinical research and technology solutions. In Vietnam, it supports trials through partnerships and digital innovations. In June 2024, IQVIA launched One Home for Sites, a platform that streamlines trial management by integrating clinical applications into a single dashboard. This enhances efficiency, reduces complexity, and supports multi-trial execution. IQVIA's investment strengthens Vietnam’s clinical research landscape.
Parexel, founded in 1982 and headquartered in Durham, North Carolina, is a leading global clinical research organization. Expanding its presence in Asia, Parexel supports the region’s growing demand for efficient and cost-effective trials. With strong capabilities in respiratory, immunology, biologics, and biosimilars, the company enhances Vietnam’s clinical research landscape by improving data quality and accelerating development.
VietStar Biomedical Research, a leading Contract Research Organization based in Vietnam, provides clinical research and regulatory services across all trial phases. The company partners with global pharmaceutical firms to support drug development in areas such as oncology, hepatitis, arthritis, and hypertension. Its ongoing work includes trials for herbal medicines and conventional drugs. With cost-effective solutions and strong regulatory expertise, VietStar plays a key role in advancing Vietnam’s clinical trials market.
Thermo Fisher Scientific operates globally through its clinical research division, PPD. It is headquartered in Waltham, Massachusetts, and was established in 1985. In Vietnam, PPD supports clinical trials using patient-centric digital tools such as AI-based pre-screening, eConsent, remote televisits, and decentralized services. These innovations improve recruitment, engagement, and data quality. The HealthUnlocked platform and 24/7 patient support further enhance participation and retention. PPD’s digital approach aligns with Vietnam’s growing clinical trials market, strengthening its role in the region.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Big Leap Research, SMART Research Corporation, CRI Vietnam Ltd., and SGS.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Phase |
|
| Breakup by Service Type |
|
| Breakup by Therapeutic Areas |
|
| Breakup by Application |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share